EUVIMEDEUVIMED entdecken
Crossref

Characterization of m6A ‐Related Genes in Tumor‐Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms

Mengmeng Sang, Qinhua Huang, Mimi Mao, Haoming Yan, Jia Ge, Rui Zhang, Wenhao Ju, Xiaorong Zhou

The FASEB Journal · 2025

DOI: 10.1096/fj.202500293rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Mengmeng Sang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Tumor-Associated Macrophages, Lung Neoplasms, Machine Learning. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nantong Municipal Health and Health Commission Scientific Research Project, College Student Practice and Innovation Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐associated macrophages (TAMs) are a vital immune component within the tumor microenvironment (TME) of lung adenocarcinoma (LUAD), exerting significant influence on tumor growth, metastasis, and drug resistance. N6‐methyladenosine (m6A) modifications regulate gene expression and various facets of cancer biology; nonetheless, the mechanisms by which they modulate gene expression in TAMs and their impact on LUAD progression remain inadequately elucidated. Single‐cell transcriptome analysis identified the macrophage m6A‐related genes (MMRGs) with high expression in TAMs and linked to m6A modifications in LUAD. The MMRGs were employed to construct 801 prognostic models by 13 different machine learning (ML) algorithms. An integrative multi‐omics approach was utilized to analyze the potential biological functions of MMRGs. Five ML algorithms were employed to discover potential biomarkers for patient stratification and precision therapy. Potential drugs for treating LUAD were identified and assessed by molecular docking and molecular dynamics, and ML was employed to determine the most promising candidates. Immunohistochemistry and immunofluorescence staining were conducted to assess MMRG expression in LUAD tissues. Seventeen MMRGs were identified in LUAD and subsequently employed to construct a prognostic model for patient stratification into high‐risk and low‐risk groups. The impact of MMRG expression on various tumor immune phenotypes, such as tumor stemness, heterogeneity, hallmark pathway enrichment, TAM infiltration, and immune landscape, was thoroughly characterized. PIM3 , HMGB2 , DUSP2 , NR4A2 , and others were recognized as promising biomarkers for patient classification and precision therapy. Furthermore, it was predicted that drugs such as BRD9876 and MK‐1775 would demonstrate therapeutic efficacy in treating LUAD, and drugs showing potential binding with DUSP2, ZNF331, FLT, and LYZ were identified. Finally, experimental validation was conducted to confirm the protein expression and distribution of DUSP2 and NR4A2 in tissues of LUAD. Our study offers valuable insights into the biological significance of MMRGs, shedding light on novel mechanisms of tumor development and immune evasion in LUAD. Furthermore, our findings have identified potential biomarkers, drug candidates, and therapeutic targets that may improve the management of LUAD in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungTumor-Associated MacrophagesLung NeoplasmsMachine LearningAdenosineImmunotherapyHumansPrognosisTumor MicroenvironmentBiomarkers, TumorGene Expression Regulation, NeoplasticAlgorithms

Stichwörter der Autor:innen

lung adenocarcinomam6A modificationmachine learningtumor microenvironmenttumor‐associated macrophages

Substanzen

AdenosineN-methyladenosineBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Nantong University, Nantong, China.
  • Department of Radiology, Nantong Tumor Hospital Affiliated to Nantong University, Nantong, China.
  • Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Department of Structural Heart Disease, National Center for Cardiovascular Disease, China and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jiangsu Province Key Laboratory in University for Inflammation and Molecular Drug Target, Nantong University, Nantong, China.

Förderung

  • National Natural Science Foundation of China
  • Nantong Municipal Health and Health Commission Scientific Research Project
  • College Student Practice and Innovation Training Program
  • Project of Nantong Municipal Health Commission

Zitieren

APA

Sang, M., Huang, Q., Mao, M., Yan, H., Ge, J., Zhang, R., Ju, W., & Zhou, X. (2025). Characterization of m6A ‐Related Genes in Tumor‐Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms. The FASEB Journal. https://doi.org/10.1096/fj.202500293rr

Vancouver

Sang M, Huang Q, Mao M, Yan H, Ge J, Zhang R, et al. Characterization of m6A ‐Related Genes in Tumor‐Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms. The FASEB Journal. 2025. doi:10.1096/fj.202500293rr

BibTeX
@article{Sang2025,
  author = {Sang, Mengmeng and Huang, Qinhua and Mao, Mimi and Yan, Haoming and Ge, Jia and Zhang, Rui and Ju, Wenhao and Zhou, Xiaorong},
  title = {Characterization of m6A ‐Related Genes in Tumor‐Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202500293rr}
}
Kostenlos starten →